Brief ACT Intervention for Problem Gambling: A Pilot Study
NCT ID: NCT07066488
Last Updated: 2025-07-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
5 participants
INTERVENTIONAL
2025-10-01
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Does ACT therapy improve health and gambling behavior?
* Is an 8-week online group therapy format viable for youth with gambling problems? Researchers will assess whether changes in health, gambling behavior, and other psychological variables are observed after eight weeks of therapy.
Participants will:
* Attend weekly online group sessions for 8 weeks
* Learn new tools that they will put into practice after the sessions
* Be required to complete evaluation questionnaires before and after the intervention and at the 3- and 6-month follow-up
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
ACT-Based Intervention for Problem Gambling
NCT07066501
Brief Online Personalised Feedback Intervention for Gambling Harm
NCT06011070
Effectiveness of ACT for Problematic Chemsex
NCT06406296
The Context of Gambling Treatment: Towards Creating an Online Service to Reduce Problem Gambling - Part Five
NCT05084885
Computer-based Training (Retraining) for People With Gambling Problems
NCT03460288
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients who meet eligibility requirements will receive psychological intervention consisting in an 8-session group on line-delivered ACT-based treatment.
The participants will be assessed through self-report instruments before and after treatment and at 3 and 6 months follow-up.
The pilot study will not include a control group.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ACT group
8 group weekly sessions including ACT methods
Acceptance and Commitment Therapy (ACT)
Acceptance and Commitment Therapy methods were focused on promoting Values clarification, Acceptance, Cognitive defusion, Committed action and Flexible attention to the present moment, and included methods such as the Garden Metaphor or defusion training.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Acceptance and Commitment Therapy (ACT)
Acceptance and Commitment Therapy methods were focused on promoting Values clarification, Acceptance, Cognitive defusion, Committed action and Flexible attention to the present moment, and included methods such as the Garden Metaphor or defusion training.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Score ≥ 3 on the Problem Gambling Severity Index (PGSI)
* Comprehension of Spanish, online connection, and signed consent
Exclusion Criteria
* Having received ACT-based psychological treatment in the last 6 months
* Problematic substance use: CAGE Adapted to Include Drugs Questionnaire (CAGE-AID) score ≥ 3
* Difficulty consistently attending online sessions
18 Years
25 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad Europea de Madrid
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Francisco Montesinos, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Universidad Europea de Madrid
David Lobato, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Universidad Europea de Madrid
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universidad Europea de Madrid
Villaviciosa de Odón, Madrid, Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025-81
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.